about
Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndromeMechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcomeProlonged perioperative myocardial ischemia in a young male: due to topical intranasal cocaine?Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.Hypertonic saline reduces inflammation and enhances the resolution of oleic acid induced acute lung injury.Determination Of The Efficacy And Side-effect Profile Of Lower Doses Of Intrathecal Morphine In Patients Undergoing Total Knee ArthroplastyComparison of the Airtraq and Truview laryngoscopes to the Macintosh laryngoscope for use by Advanced Paramedics in easy and simulated difficult intubation in manikins.Optimized aerosol delivery to a mechanically ventilated rodent.Role of potassium and calcium channels in sevoflurane-mediated vasodilation in the foeto-placental circulation.Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial.Carbon dioxide and the critically ill--too little of a good thing?Acidosis in the critically ill - balancing risks and benefits to optimize outcome.Etiologies, diagnostic work-up and outcomes of acute respiratory distress syndrome with no common risk factor: a prospective multicenter study.Bench-to-bedside review: carbon dioxide.Hypocapnia.Learning and performance of tracheal intubation by novice personnel: a comparison of the Airtraq and Macintosh laryngoscope.The Airtraq as a rescue airway device following failed direct laryngoscopy: a case series.The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist.Aerosol-mediated delivery of AAV2/6-IκBα attenuates lipopolysaccharide-induced acute lung injury in rats.Clinical review: gene-based therapies for ALI/ARDS: where are we now?Can 'permissive' hypercapnia modulate the severity of sepsis-induced ALI/ARDS?Permissive hypercapnia--role in protective lung ventilatory strategies.Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress SyndromeMesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injuryLung stem cells--from an evolving understanding to a paradigm shift?Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome.Sepsis protects the myocardium and other organs from subsequent ischaemic/reperfusion injury via a MAPK-dependent mechanismHypercapnia induces cleavage and nuclear localization of RelB protein, giving insight into CO2 sensing and signaling.Tracheostomy procedures in the intensive care unit: an international surveyPermissive hypercapnia: role in protective lung ventilatory strategies.Maternal brain death and somatic support.A comparison of videolaryngoscopes for tracheal intubation in predicted difficult airway: a feasibility study.Maternal brain death--an Irish perspective.Hypercapnia: permissive and therapeutic.Hypercapnic acidosis attenuates pulmonary epithelial stretch-induced injury via inhibition of the canonical NF-κB pathwayClinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype?Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.Comparison of the Glidescope and Pentax AWS laryngoscopes to the Macintosh laryngoscope for use by advanced paramedics in easy and simulated difficult intubationMultidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.
P50
Q26740632-C74FAAF3-38D2-45F2-96EC-48EAEA1BB7C8Q27006565-C59E3FD9-1802-459A-93AC-CF809C569BB3Q28374514-388B35A2-EDBE-441B-97E7-5B1D922DF174Q31150571-BE2C53E2-A666-4B59-84FF-2FE230BC33DCQ33350089-83C5612C-49B5-4DDD-8D2D-4FA3799C4ED7Q33371794-C131F67D-555B-4C04-81F3-7232B0CA3985Q33409139-A1255A1A-38E3-4E4C-BA6F-F930A3EB4617Q33439110-B989E72C-B22B-4200-8FAD-D70B50826685Q33465323-C326E364-8FC7-4435-A9A3-8D475204A81CQ33568643-BF9900F8-F7E0-4A98-9CAF-85CFD0411FFDQ33696868-402B8A74-C46D-444F-9E0D-8A114685C1CAQ33751541-0FA2765C-6226-48BD-9DE4-CE72F82A2510Q33752303-04AE93F0-F40D-414B-B8F4-8B1B7A38D121Q33812388-95ABA3C8-A3CE-44CE-830C-B63B47673246Q33919106-07C87F7C-A10A-47A3-8AF0-4108DDC50AF5Q34136945-9FE3E971-AE0B-40DC-9AD9-C9388E3E2936Q34540917-ED9D1920-8DEF-4EDB-9434-E334B79DC4BBQ34628898-5C4FC075-0B70-4C2C-9F85-555BB45D000EQ34751979-66CEF33C-5004-472F-AFC7-123D27A4C05CQ34999489-E47333B7-6483-4BB4-B3DB-59A301F5CEA6Q35558172-37D72075-6F03-4635-BF08-7DA731AFA063Q35559661-7E0F93B5-1FE5-4830-B7E4-45475D3C2247Q35628608-D19C3111-B641-48A7-A706-CA05EA6F48B8Q35652003-8C79B1E6-9FA8-4438-9EBE-27859DDFE7F9Q35809674-CEB710F5-33FE-4365-9BA3-3F169259A71EQ35840663-2D926DD1-235F-493B-9867-1B5A2B71F81DQ35883490-F69E620A-DA2D-48AB-BC71-9B306A4C597EQ35883643-B97A4DDC-8B39-4D10-A2C6-27A0E50E197AQ35922160-ABD716BF-B2B6-4612-B27A-46DAD1563358Q35954476-56C29FED-86EC-4873-A985-4383EAA96A6EQ36014184-B958A270-5619-4D51-BD96-937383FBEEE7Q36262590-1F8FF5C9-CF1A-4101-8385-A37F6E029B6DQ36285526-EECCD686-AF70-46A6-9AF6-B3D73D494CC0Q36381158-0EEA89EC-854B-4A86-907A-E7BE4E1964ABQ36472366-61CAF69C-E7DA-41BA-B9B1-E8F46B9E360BQ36712297-10613353-7358-4E97-A498-C2BE8D42B910Q36925671-2E6A888C-566F-4534-BD06-1011DC6E7531Q37187656-7CC30578-F648-4D35-A9E8-C495751BE035Q37209347-FDEEB03D-2117-410B-8DCF-D91771768E94Q37471610-777888F0-0654-4043-A974-7F95FE27E70A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
John G Laffey
@ast
John G Laffey
@en
John G Laffey
@es
John G Laffey
@nl
John G Laffey
@sl
type
label
John G Laffey
@ast
John G Laffey
@en
John G Laffey
@es
John G Laffey
@nl
John G Laffey
@sl
prefLabel
John G Laffey
@ast
John G Laffey
@en
John G Laffey
@es
John G Laffey
@nl
John G Laffey
@sl
P106
P21
P31
P496
0000-0002-1246-9573